Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation

Chinese Journal of Cancer

Volumn 29, Issue 9, 2010, Pages 781-786

  Song, Yan ^a   Cao, Zhi ^a   Li, Ling ^a   Zhang, Hong Tu ^a   Zhang, Xun ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Blimp 1 protein; Diffuse large B cell lymphoma (DLBCL); Hans model; Heterogeneous; Prognosis

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERFERON REGULATORY FACTOR 4; PREDNISOLONE; PROTEIN BCL 6; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HANS CLASSIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 79953163817     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10082     Document Type: Article

References (16)

1. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma [M]. Jaffe ES, Harris NL, Stein H, et al., eds. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoidtissues. Lyon: IARC Press, 2001: 171-174.
2. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J]. Nature, 2000, 403(6769): 503-511.
3. Rosenwaid A, Wrisht G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma [J]. N Engl J Med, 2002, 346(25): 1937-1947.
4. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J]. Blood, 2004, 103(1): 275-282.
5. Turner CA Jr, Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytas into immunoglobulin secreting cells [J]. Cell, 1994, 77(2): 297-306.
6. Calame K. Activation-dependent induction of Blimp-1 [J]. Immunology, 2008, 20(3): 259-264
7. Pileri SA, Dirnhofer S, Went P, et al. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification [J]. Histopathology, 2002, 41 (6): 482-509.
8. Chang CC, McClintock S, Ronald P, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma [J]. Am J Surg Pathol, 2004, 28(4): 464-470.
9. Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach [J]. Blood, 2005, 106(4): 1164-1174.
10. Shiozawa E, Yamochi-Onizuka T, Takimoto M, et al. The GCB subtype of diffuse large B-cell lymphomais less frequent in Asian countries [J]. Leuk Res, 2007, 31(11): 1579-1583.
11. Zettl A, Meister S, Katzenberger T, et al. Immunohistochemical analysis of B-cell lymphoma using microarrays identifies particular phenotypic profiles of B-cell lymphomas [J]. Histopathology, 2003, 43(3): 209-219.
12. Shaffer AL, Lin KI, Kuo TC, et al. Blimp-1, orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program [J]. Immunity, 2002, 17(1): 51-62.
13. Tam W, Gomez M, Chadburn A, et al. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas [J]. Blood, 2006, 107(10): 4090-4100.
14. Kallies A, Hasbold J, Tarlinton DM, et al. Plasma edl ontogeny defined by quantitative changes in blimp-1 expression [J]. J Exp Med, 2004, 200(8): 967-977.
15. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, et al. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pro-plasma memory B cells [J]. Immunity, 2003, 19 (4): 607-620.
16. Nutt SL, Fairfax KA, Kallies A. Blimp-1 guides the fate of effect of B and T cells [J]. Nat Rev Immunol, 2007, 7(12): 923-927.